Friday, February 23, 2024
wellness India Expo
Home Tags Boehringer Ingelheim

Tag: Boehringer Ingelheim

Boehringer Ingelheim appoints Gagandeep Singh as MD & Head of Human...

Singh joins Boehringer Ingelheim from AstraZeneca, where he was the Managing Director for India and Africa Cluster Head

Boehringer Ingelheim India signs MoU with Maharashtra govt to strengthen stroke...

As part of the MoU, Boehringer Ingelheim India through the ANGELS initiative will equip hospitals with capacity building of multidisciplinary stroke teams to access valuable resources

Aragen expands discovery research agreement with Boehringer Ingelheim

The partnership also allows for the integrated up-scaling of compounds for larger pre-clinical studies.......................

Lupin achieves key milestones for its potential therapy to treat difficult...

Lupin’s proprietary MEK inhibitor compound is planned for clinical development in combination with Boehringer Ingelheim’s KRAS inhibitor pipeline to address KRAS-driven cancer...........................

Boehringer Ingelheim India launches VAXXITEK® HVT + IBD, a single shot...

VAXXITEK® HVT + IBD provides life-long immunity against Infectious Bursal Disease and Marek's Disease. It is the first vector vaccine launched in the avian market.............................

Boehringer Ingelheim partners CDR-Life to develop antibody based therapeutics for Geographic...

Together the partners will advance CDR-Life’s preclinical antibody fragments targeting a key pathway in geographic atrophy (GA) besides developing novel treatments and technologies for patients who have only inadequate treatment options........................

Healthcare firms finding obesity market a challenge to penetrate, says GlobalData

The latest failure of three anti-obesity drugs to provide the anticipated results could lead to the companies taking a cautious approach while investing to develop further drugs in the area.............